Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Change in Accured Expenses: 2017-2024

Historic Change in Accured Expenses for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $9.7 million.

  • Bicycle Therapeutics' Change in Accured Expenses fell 88.30% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year increase of 157.68%. This contributed to the annual value of $9.7 million for FY2024, which is 304.42% up from last year.
  • As of FY2024, Bicycle Therapeutics' Change in Accured Expenses stood at $9.7 million, which was up 304.42% from $2.4 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Change in Accured Expenses ranged from a high of $12.4 million in FY2022 and a low of $1.2 million during FY2021.
  • Moreover, its 3-year median value for Change in Accured Expenses was $9.7 million (2024), whereas its average is $8.2 million.
  • In the last 5 years, Bicycle Therapeutics' Change in Accured Expenses soared by 943.21% in 2022 and then slumped by 80.60% in 2023.
  • Bicycle Therapeutics' Change in Accured Expenses (Yearly) stood at $4.8 million in 2020, then slumped by 75.48% to $1.2 million in 2021, then surged by 943.21% to $12.4 million in 2022, then tumbled by 80.60% to $2.4 million in 2023, then skyrocketed by 304.42% to $9.7 million in 2024.